New Market Research Report: Exact Sciences Corporation (EXAS) - Product Pipeline Analysis, 2014 Update
Exact Sciences Corporation (Exact) is a molecular diagnostics company. It focuses on the early detection and prevention of colorectal cancer. The company's proprietary non-invasive stool-based deoxyribonucleic acid (sDNA) screening technology is used to detect presence of colorectal pre-cancer and cancer. Its Cologuard test includes methods detects pre-cancerous polyps, DNA that sheds into stool and four stages of colorectal cancer. Exact contains DNA markers and protein markers to detect blood in stool utilizing an antibody-based Fecal Immunochemical Test (FIT). EXACT is...
View full press release